协议支持通过生存护理计划改善临床结果,使治疗相关副作用和疾病复发的早期检测和干预成为可能
美国亚特兰大-2018年2月1日,星期四
Elekta(EKTA-B.ST)今天宣布,它已经与
Equicare Health, a leader in developing chronic care models for cancer survivorship that improve patient outcomes and maximize cancer centers’ operational efficiencies. Under the terms of the agreement, Elekta will now offer EQUICARE CS™ and Equicare’s Active Patient Portal to current and future users of Elekta’s MOSAIQ® Oncology Electronic Health Record (EHR). EQUICARE CS and the Active Patient Portal complement MOSAIQ, facilitating communication between patients and clinicians with no geographic restrictions. Patients can receive updates on their care plans, provide feedback and patient reported outcomes through the platform. Clinical information is integrated into MOSAIQ directly from EQUICARE CS.
莫萨伊克is a leading open system that also provides actionable analytics to support improvements in the quality and cost of care. MOSAIQ is designed for interoperability with a broad array of digital health solutions to drive the open exchange of information and promote an all-inclusive workflow empowering patient care providers.
Equicare全球销售副总裁Margaret Nash说:“客户群不断变化的需求要求我们超越单个软件解决方案所能提供的功能。“Equicare的产品为有效管理和沟通癌症患者提供了独特且急需的解决方案。在MOSAIQ全面EHR的背景下使用我们的数字解决方案的癌症中心现在将拥有一个强大的系统,用于将这些患者互动与治疗管理流程连接起来。这使得整个护理团队能够记录和回顾患者的完整病史,从患者的第一次筛查访视开始,一直延续到治疗的最后一天,在优化肿瘤资源利用的同时改善患者的预后。”bob体育网赌
EQUICARE CS用于协调癌症护理,管理患者导航,并根据医学研究bob体育网赌所和美国临床肿瘤学会的建议促进生存计划的制定。癌症护理中心需要病人导航和生存计划才能获得癌症委员会的认可。活动患者门户允许正在接受癌症治疗的患者访问最新的医疗信息,了解预定的预约、实验室结果和医疗记录,以及与护理团队成员发送/接收安全消息。它还通过汇总问卷调查中收集的有价值的数据来深入了解患者群体,这些数据有助于衡量整个患者群体的长期临床结果。
“Elekta is committed to ensuring that our digital solutions interface seamlessly with systems and applications across the evolving healthcare ecosystem that share our goal of advancing patient care,” said Andrew Wilson, Vice President of Global Marketing for Software Solutions at Elekta. “We believe that the combination of MOSAIQ and Equicare’s offerings gives users unparalleled resources for effectively managing the entire oncology care continuum and improving survival and quality of life for cancer survivors.”
###
关于Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.nbwhprint.com